Programming - BCVS Scientific Sessions 2020

Registration Information

Want to watch #BCVS20 but didn't sign up in time? Purchase access here:

Online Meeting
Virtual Sessions

If you already attended #BCVS20, you can re-watch for 90 days without purchasing additional access. Log in to PHD first for a faster experience.

BCVS 2020 available OnDemand™

Our 2020 virtual meeting was a great success! Now, all registered attendees have access to watch any virtual session at any time for 90 days (until October 30th, 2020).

Watch when you want!

Did you miss a concurrent session that you really wanted to see? Are you interested in the 25 hours of CME/CE accreditation available? Want to watch a session again? No problem!

If you already registered for BCVS 2020, just enter the sessions by clicking here: Watch OnDemand Sessions. (We recommend bookmarking this link.) To access BCVS ePosters, recorded moderated poster sessions, exhibits and more, visit our Heart Hub. The content on the Heart Hub will stay open-access.

What if I didn't register during or before BCVS 2020?

If you didn't attend BCVS 2020 while it was happening but would like to see the sessions now, Purchase access to buy OnDemand™. The cost is $99 for AHA Members, and $199 for Non-members. You'll be able to access the sessions for up to two years (July 2022). BCVS OnDemand contains nearly 30 hours of meeting content, 80 presentations and 25 hours of CME/CE.

Program & Agenda

Visit the BCVS 2020 Heart Hub for:

  • Up-to-the-minute conference schedule
  • Early Career and breakout Zoom sessions
  • Exhibitors
  • CME/CE information


AHA Basic Cardiovascular Sciences | Visit the BCVS Heart Hub - The heart of your virtual event experience. Access >

About this Meeting

The 15th annual BCVS 2020 Scientific Sessions has become the premier conference for molecular cardiovascular biology and disease. Sponsored by the American Heart Association Basic Cardiovascular Sciences Council, the world’s leading organization of cardiovascular scientists, the conference attracts leading researchers in fields such as microRNAs, cardiac gene and cell therapy, cardiac development and most recently tissue engineering and iPS cells.

The planned agenda includes 15 fast-paced sessions during 3½ days, set in a forum that promotes the relaxed exchange and discussion of cutting edge research in molecular and translational cardiovascular biology and disease. The program includes a diversity of speakers representing the best cardiovascular scientists from around the world.

In addition, the symposium will be of great value to scientists and executives of pharmaceutical companies and biotechnology firms who are in the cardiovascular space.

Target Audience

  • Basic cardiovascular scientists
  • Molecular/cellular biologists
  • Physiologists
  • Translational investigators
  • Clinical trialists
  • Practicing cardiologists
  • Cardiovascular nurses and pharmacists

Learning Objectives

At the conclusion of the conference, participants will be able to:

  1. Discuss the latest research on cardiac metabolism and their implications for clinical practice.
  2. Identify critical areas of research and research gaps in heart failure.
  3. Describe current knowledge gaps in research and understanding of the cardiopulmonary effects of e-cigarette use.
  4. Describe opportunities to bring a greater emphasis on translational research to your work.
  5. Discuss the cardiovascular effects of traditional, targeted, and immunological therapies for cancer patients and on their role in the management and prevention of these conditions.
  6. Describe the potential role of and challenges involved in the use of big data analytics to precision medicine to guide cardiovascular research and patient care, and their implications for your work.

Preliminary Program

Below you'll find the session times. For more details on some presentations, see the BCVS 2020 Preliminary Program (PDF).

Monday, July 27

Time (all times are Central)
12:30pm - 1:00pm

BCVS 2020 Opening Welcome
Mitch Elkind, MD, AHA President, New York, New York
Elizabeth McNally, MD, PHD, BCVS Council Chair, Chicago, Illinois

1:00pm - 2:00pm

Concurrent Session 1A: Beyond the Heart: Systemic Effects of Pathogenic Cardiac Remodeling
Moderator: Gregory Aubert, MD, Chicago, Illinois

Concurrent Session 1B: Cutting-edge Approaches to Targeting Complex Cardiomyopathies
Moderator: Jil Tardiff, MD, PhD, Tucson, Arizona

2:00pm - 3:00pm

Moderated Poster Session 1A: Sarcomeric Function & Contractility
Poster Professor: Danish Sayed, PhD, Newark, New Jersey

Moderated Poster Session 1B: Ion Channels and Arrhythmias
Poster Professor: Ravi Shah, MD, Boston, Massachusetts

3:00pm - 4:00pm

Concurrent Session 2A: Cardiovascular Risk Factors-Nicotine Use, Diet and Physical Activities as Modulators
Moderator: Loren Wold, PhD, Columbus Ohio

Concurrent Session 2B: Covid-19 and Cardiovascular Disease
Moderator: Mina Chung, MD, Cleveland, Ohio

4:00pm - 5:00pm

ACS Japanese: Inflammation and Cardiac Remodeling in Heart Failure
Moderator: Junichi Sadoshima, MD, Newark, New Jersey

ACS Korean: Cellular and Molecular Mechanisms of Heart Failure
Moderator: Young-sup Yoon, MD, Atlanta, Georgia

Tuesday, July 28

Time (all times are Central)
10:00am - 11:00am

Concurrent Session 3A: Molecular Predictors & Markers of Heart Failure Progression
Moderator: Kristine Deleon-Pennell, PhD, Charleston, South Carolina

Concurrent Session 3B: Cardiac Effects of Oxidation and Inflammation
Moderator: Ameen Ismahil, PhD, Birmingham, Alabama

11:00am - 12:00pm

Concurrent Session 4A: Apoptosis, Necrosis and Autophagy in Heart Disease
Moderator: Asa Gustafsson, PhD, La Jolla, California

Concurrent Session 4B: Novel Pathogenic Pathways in Cardiac Remodeling: Early vs. Late
Moderator: John Calvert, PhD, Suwanee, Georgia

12:00pm - 1:00pm

General Session 5: Keynote Lecture - All is in Flux: Cardiac Metabolism in Transition
Moderator: Ivor Benjamin, MD, Milwaukee, Wisconsin
Speaker: Heinrich Taegtmeyer, MD, Houston, Texas

1:30pm - 2:30pm

Early Career Session: Amplify the Signal, Not the Noise
Moderator: Priscila Sato, PhD, Philadelphia, Pennsylvania

ACS SAHA: Research Advances to Treat Heart Failure
Moderator: Sathyamangla Naga Prasad, PhD, Cleveland, Ohio

2:30pm - 3:30pm

Moderated Poster Session 2A: Myocardial Ischemia, Oxidative Stress and Cardioprotection
Poster Professor: Jean Bopassa, PhD, UTHealth, San Antonio, Texas

Moderated Poster Session 2B: Signal Transduction Pathways
Poster Professor: Joan Heller Brown, PhD, La Jolla, California

3:30pm - 4:30pm

Concurrent Session 6A: Harnessing Precision Medicine to Treat Cardiovascular Disease
Moderator: Renzhi Han, PhD, Columbus, Ohio

Concurrent Session 6B: Novel Animal Models and Translational Insights
Moderator: Martin Petroff, PhD, La Plata, Argentina

Wednesday, July 29

Time (all times are Central)
10:00am - 11:00am

Concurrent Session 7A: HfpEF in Metabolic Diseases
Moderator: Jonathan Kirk, Maywood, Illinois

Concurrent Session 7B: Cardiotoxicity of Cancer Therapeutics: Mechanisms and Potential Therapies
Moderator: Richard Becker, MD, Cincinnati, Ohio

11:00am - 12:00pm

General Session 8: Molecular Mechanisms of Cardiac Hypertrophy (BCVS-HFA Joint Session)
Moderator: Rebekah Gundry, PhD, Omaha, Nebraska

Workshop 1 -- Nailing Your Statistics: Rigorous Analysis for Grants & Papers
(Hosted by Circulation Research)
Moderator: Jane Freedman, MD, Worchester, Massachusetts

12:30pm - 1:30pm

General Session 9A: Outstanding Early Career Investigator Award Competition
Moderator: Hesham Sadek, MD, PhD, Dallas, Texas

General Session 9B: Metabolism and Redox Mechanisms in Heart Failure
Moderator: Mahesh Gupta, PHD, Chicago, Illinois

1:30pm - 2:30pm

General Session 10: Women in Science: Go for It (AHA Zoom)
Moderator: Rong Tian, MD, Seattle, Washington

ACS ACRE: Critical Signaling Pathways in Heart Failure
Moderator: Faqian Li, MD, Minneapolis, Minnesota

2:30pm - 3:30pm

Moderated Poster Session 3A: Systems Approach to Cardiovascular Biology
Poster Professor: Young-sup Yoon, MD, Atlanta, Georgia

Moderated Poster Session 3B: Inflammation and the Cardiovascular System
Poster Professor: Beata Wolska, PhD, Chicago, Illinois

3:30pm - 4:30pm

Concurrent Session 11A: Molecular & Cellular Therapy for Heart Failure
Moderator: Li Qian, PhD, Chapel Hill, North Carolina

Concurrent Session 11B: Diastolic & Contractile Dysfunction in Heart Failure
Moderator: John Ralphe, MD, Madison, Wisconsin

4:30pm - 5:30pm

General Session 12: Genomic, Genetic and Epigenetic Mechanism of Heart Failure
Moderator: Susan Cheng, MD, Los Angeles, California

Workshop 2: The Practice of Biomedical Research: Honesty Transparency and Early Career Funding Opportunities
Moderator: Leslie Leinwand, PhD, Boulder, Colorado

Thursday, July 30

Time (all times are Central)
10:00am - 11:00am

Concurrent Session 13A: Extracellular Matrix; Fibroblasts and More
Moderator: Onur Kanisicak, PhD, Cincinnati, Ohio

Concurrent Session 13B: Regulation of Small RNAs in Heart Failure
Moderator: Jaunian Chen, PhD, Los Angeles, California

11:00am - 12:00pm

Concurrent Session 14A: Cardiac Arrhythmias: from Basic Mechanisms to Precision Medicine
Moderator: Steven Houser, PhD, Philadelphia, Pennsylvania

Concurrent Session 14B: Systems Approaches to Cardiac Disease: Novel Mechanisms
Moderator: Chengxue Qin, DPhil, Melbourne, Australia

12:00pm - 1:00pm

Moderated Poster Session 4A: Clinical/Translational Research
Poster Professor: Glenn Rowe, PhD, Birmingham, Alabama

Moderated Poster Session 4B: Genetics and Genomics of Cardiovascular Disease
Poster Professor: Sarah Schumacher, PhD, Cleveland, Ohio

Conference adjourns